Large Volume Parenteral (LVP) Market Forecast To Reach $21.37 Billion By 2030: Key Trends Explained

Large Volume Parenteral (LVP) Market Report

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Large Volume Parenteral (LVP) Market Set To Climb From $14.76 Billion In 2026 To $21.37 Billion By 2030

The large volume parenteral (lvp) market size has experienced robust growth in recent years. It is projected to expand from $13.53 billion in 2025 to $14.76 billion in 2026, at a compound annual growth rate (CAGR) of 9.1%. This historic growth is attributable to factors such as rising hospitalization rates, increased utilization of intravenous fluid therapy, a surge in surgical procedures, the expansion of critical care infrastructure, and advancements in infectious disease treatment.

The large volume parenteral (lvp) market is poised for significant expansion over the coming years, with its size projected to reach $21.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. This anticipated growth during the forecast period is driven by factors such as an expanding aging population, the rising incidence of chronic diseases, increased demand for parenteral nutrition, the development of healthcare infrastructure in emerging markets, and an uptick in emergency and trauma care services. Furthermore, key trends expected during this period involve a growing preference for non-PVC and eco-friendly LVP packaging, the proliferation of ready-to-use and pre-mixed infusion solutions, a heightened focus on ensuring sterility and controlling contamination, the increasing application of LVPs in critical care and emergency medicine, and a general rise in hospital-based infusion therapy volumes.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=75552767&type=smp&name=Large%20Volume%20Parenteral%20%28LVP%29%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Large Volume Parenteral (LVP) Market Expansion Drivers: What’s Shaping Future Growth?

The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the large-volume parenteral market in the future. Chronic diseases are defined as health conditions or ailments typically persisting for three months or more, with the potential to deteriorate over time. The increase in these diseases primarily stems from factors such as tobacco consumption, exposure to smoke, and inadequate nutrition. Individuals suffering from these conditions need a suitable balance of vital nutrients to maintain their well-being. The parenteral route of administration ensures accurate pharmaceutical dosing as most medications are directly absorbed into the bloodstream, bypassing the digestive system. For example, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported in September 2023 that 41 million deaths, representing 74% of total fatalities globally each year, were attributable to non-communicable diseases (NCDs) or chronic diseases. Consequently, the rising incidence of chronic diseases is a significant driver for the growth of the large-volume parenteral market.

Large Volume Parenteral (LVP) Market Segment Performance And Emerging Opportunities

The large volume parenteral (lvp) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Large Volume Parenteral (LVP) Market Strategic Trends: What Defines The Next Growth Phase?

Leading companies in the large volume parenteral (LVP) market are concentrating on developing smart infusion device innovations, such as intelligent large-volume infusion pumps. This focus is driven by the growing demand for safer, more automated, and connected intravenous therapy, stimulated by an increase in hospital-based infusion services, remote patient monitoring, and the push for standardized, error-resistant medication delivery. An intelligent large-volume infusion pump is designed to administer high-volume IV fluids (LVP) with integrated dose-error reduction software, connectivity for smart drug libraries, and alarm management features. Unlike traditional infusion pumps that depend solely on manual programming and limited automation, these next-generation devices help prevent dosing mistakes, reduce workflow burden, and integrate with hospital IT systems. As an illustration, in April 2024, Baxter International Inc., a US-based pharmaceutical and medical-device company, obtained U.S. FDA clearance for its Novum IQ Large-Volume Infusion Pump, which includes Dose IQ smart-dose software. This device supports high-rate fluid delivery, including large-volume infusions, offers safety features such as drug library integration to minimize dosing errors, and enables connectivity to hospital electronic medical records and smart monitoring platforms. By facilitating the safe, automated, and reliable infusion of large volumes, the Novum IQ pump aids healthcare providers in enhancing infusion accuracy, reducing the risk of dosing mistakes, and streamlining high-volume IV therapy workflows.

Large Volume Parenteral (LVP) Market Key Players: Which Companies Lead Industry Competition?

Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare

View The Full Large Volume Parenteral (LVP) Market Report:

https://thebusinessresearchcompany.com/report/large-volume-parenteral-LVP-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Large Volume Parenteral (LVP) Market Largest Region: Which Geography Holds The Biggest Share?

North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model